KURTIS CRAWFORD: Open Payments
NPI 1033580964 · SAND SPRINGS, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 79 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $204 · 2025 $1,936
Food & beverage: $1,934Travel & lodging: $2
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $384 |
| GENZYME CORPORATION | 12 | $257 |
| Novartis Pharmaceuticals Corporation | 9 | $225 |
| Genentech USA, Inc. | 7 | $208 |
| Genentech, Inc. | 2 | $151 |
| GlaxoSmithKline, LLC. | 11 | $145 |
| CSL Behring | 9 | $140 |
| Blueprint Medicines Corporation | 1 | $122 |
| Regeneron Healthcare Solutions, Inc. | 3 | $77 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $46 |
Products named: Xolair, DUPIXENT, AIRSUPRA, AYVAKIT, Rhapsido, FASENRA, TRELEGY ELLIPTA, Andembry.
Industry payments across OK — which companies pay providers there.
